BUONVICINO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 2.995
EU - Europa 1.806
AS - Asia 1.348
SA - Sud America 164
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 36
OC - Oceania 13
Totale 6.451
Nazione #
US - Stati Uniti d'America 2.930
RU - Federazione Russa 611
IT - Italia 476
SG - Singapore 374
CN - Cina 351
HK - Hong Kong 216
PL - Polonia 206
BR - Brasile 123
IE - Irlanda 122
VN - Vietnam 106
KR - Corea 90
SE - Svezia 82
FR - Francia 69
BD - Bangladesh 66
DE - Germania 56
FI - Finlandia 45
GB - Regno Unito 44
CA - Canada 43
CH - Svizzera 38
IN - India 30
NL - Olanda 24
ID - Indonesia 20
JO - Giordania 20
AR - Argentina 17
JP - Giappone 17
AU - Australia 12
CI - Costa d'Avorio 11
EC - Ecuador 10
MX - Messico 10
UA - Ucraina 9
PK - Pakistan 8
LT - Lituania 7
ES - Italia 6
VE - Venezuela 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
IQ - Iraq 5
MY - Malesia 5
SA - Arabia Saudita 5
TR - Turchia 5
CR - Costa Rica 4
IL - Israele 4
KZ - Kazakistan 3
MA - Marocco 3
PR - Porto Rico 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
BE - Belgio 2
BJ - Benin 2
CO - Colombia 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
KE - Kenya 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.363
Città #
Santa Clara 497
Ashburn 439
Singapore 256
Warsaw 204
Hong Kong 197
Fairfield 184
San Jose 161
Dublin 122
Chandler 119
Milan 102
Seattle 90
Seoul 90
Woodbridge 88
Houston 83
Cambridge 82
Council Bluffs 76
Beijing 67
Hefei 60
Florence 56
Ann Arbor 51
Wilmington 49
Altamura 48
Los Angeles 47
Lawrence 46
Dearborn 44
Lauterbourg 39
Bern 38
Buffalo 37
Dallas 37
Moscow 33
Ho Chi Minh City 32
Munich 32
Princeton 28
The Dalles 28
Rome 26
Kent 25
New York 23
Boston 21
Figino 21
São Paulo 21
Shanghai 20
Hanoi 19
Medford 17
Helsinki 16
Jakarta 16
Phoenix 16
Tokyo 16
Turku 16
San Diego 15
Clifton 14
Toronto 13
Chicago 12
Dong Ket 12
Orem 12
Abidjan 11
Lappeenranta 11
London 11
Melbourne 11
Bologna 9
Denver 9
Mumbai 9
Paris 9
Centro 8
Venice 8
Hillsboro 7
Montreal 7
Amsterdam 6
Belfast 6
Brooklyn 6
Chennai 6
Frankfurt am Main 6
Gavirate 6
Bari 5
Catania 5
Haiphong 5
Naples 5
North Bergen 5
Norwalk 5
Rio de Janeiro 5
San Francisco 5
Shenzhen 5
Turin 5
Atlanta 4
Boardman 4
Brasília 4
Guangzhou 4
Hangzhou 4
Johannesburg 4
Kunming 4
Kyiv 4
Louisville 4
Mexico City 4
Miano 4
Portsmouth 4
Redmond 4
Redondo Beach 4
San Antonio 4
Amman 3
Ankara 3
Belo Horizonte 3
Totale 4.178
Nome #
"β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells, 299
Trigeminal ganglion transcriptome analysis in 2 rat models of medication-overuse headache reveals coherent and widespread induction of pronociceptive gene expression patterns 278
Dexpramipexole improves bioenergetics and outcome in experimental stroke 258
Dexpramipexole Enhances K+ Currents and Inhibits Cell Excitability in the Rat Hippocampus In Vitro 248
Ethanol neurotoxicity is mediated by changes in expression, surface localization and functional properties of glutamate AMPA receptors 240
Neuroimmunological characterization of a mouse model of primary progressive experimental autoimmune encephalomyelitis and effects of immunosuppressive or neuroprotective strategies on disease evolution 235
Repurposing of dexpramipexole to treatment of neonatal hypoxic/ischemic encephalopathy 230
Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis 222
Dexpramipexole enhances hippocampal synaptic plasticity and memory in the rat 214
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 214
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 211
Increased Lacrimal Fluid Level of HMGB1 in Vernal Keratoconjunctivitis 202
β3-Adrenoceptors as Putative Regulator of Immune Tolerance in Cancer and Pregnancy 196
Glucose deprivation converts poly(ADP-ribose) polymerase-1 hyperactivation into a transient energy-producing process. 193
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice 190
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 189
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses 184
Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice 184
Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury 182
Effects of cluster headache preventatives on mouse hypothalamic transcriptional homeostasis 179
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound. 165
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 164
Histone Deacetylase Inhibitors Counteract CGRP Signaling and Pronociceptive Sensitization in a Rat Model of Medication Overuse Headache 163
Adenosine A2B receptors differently modulate oligodendrogliogenesis and myelination depending on their cellular localization 162
Therapeutic hypothermia: Turning humans into cold-blooded ectotherms via adenosine receptors 158
Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis 157
Neuroprotection induced by dexpramipexole delays disease progression in a mouse model of progressive multiple sclerosis 145
Treatment with Non-specific HDAC Inhibitors Administered after Disease Onset does not Delay Evolution in a Mouse Model of Progressive Multiple Sclerosis 144
Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis 136
The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis 136
SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure 114
Cancer cell death induced by the NAD antimetabolite Vacor discloses the antitumor potential of SARM1 93
Piezo1, F-Actin Remodeling, and Podocyte Survival and Regeneration 84
Anti-CGRP monoclonal antibodies counteract establishment of food aversive memories and chemotherapy-induced anorexia and weight loss 60
The anti-CGRP mAb Fremanezumab reverts the anti-inflammatory effects of CGRP in vitro but does not alter disease evolution in a mouse model of progressive multiple sclerosis 41
Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis 40
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia 39
Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception 28
Reduction of opioid withdrawal symptoms and opioid-induced hyperalgesia by subcutaneous sumatriptan reveals central neuromodulation 25
New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice 25
Early exposure of NOD/ShiLtJ mice to Freund's adjuvant prompts delayed, spontaneous progressive encephalomyelitis 24
Totale 6.451
Categoria #
all - tutte 18.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022211 0 0 8 7 9 19 11 27 15 18 39 58
2022/2023589 42 144 41 22 26 94 70 25 49 9 20 47
2023/2024237 5 20 32 5 23 27 6 59 5 16 31 8
2024/20251.650 56 150 107 266 419 201 31 127 78 46 68 101
2025/20262.418 276 251 159 180 270 78 244 155 191 187 122 305
2026/2027359 86 134 139 0 0 0 0 0 0 0 0 0
Totale 6.451